Kush Parmar Entrada Therapeutics, Inc. (TRDA) insider trading activity

TRDA Quotes by TradingView

KUSH PARMAR Transaction History

Date Transaction Value Shares Traded Form
Nov 02 2021
BUY
Open market or private purchase
$5,000,000 $20.0 p/Share
250,000
Nov 02 2021
BUY
Conversion of derivative security
-
3,827,224

Also insider at

FVAM
5:01 Acquisition Corp. Financial Services
Co-CEO
FIXX
Homology Medicines, Inc. Healthcare
Director
AKUS
Akouos, Inc. Healthcare
Director
VOR
Vor Biopharma Inc. Healthcare
Director
RLYB
Rallybio Corp Healthcare
Director
KP

Kush Parmar

Director
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRDA